Our in-depth, comprehensive research delivers impactful and non-consensus fundamental analysis to a global client base. Our coverage universe spans over 50 Therapeutic stocks across the US and EU and is a blend of both Small cap and Large cap companies.
Our unbiased portfolio consultation and hedging strategies are tailored to match each client's goals, horizon, and mandate. Each position is carefully considered in this hands-on process to maximize potential while maintaining risk management protocols.
Using our deep industry knowledge, Cross Current Research offers individualized custom research to help clients gain a better understanding of a particular market segment, treatment paradigm, or company R&D program.
Innovation continues to push the bounds of science and medicine. To keep up with these developments our coverage from over a dozen annual medical conferences assist clients in appreciating these new opportunities and competitive landscapes.